Dr. John M. Bennett is Professor Emeritus of Medicine, Pathology and Laboratory Medicine at the University of Rochester Medical Center, in Rochester, New York. He received his undergraduate degree from Harvard University and his medical degree from Boston University. Postgraduate training included an internship at Massachusetts Memorial Hospital, a residency in medicine at Beth Israel Hospital, a fellowship in hematology at Boston City Hospital and Tufts University.
From 1963-1966 he was head of the hematology laboratories at the Beth Israel Hospital in Boston. He served in the USPHS as Head of the diagnostic bone marrow laboratories in the NIH/Clinical Center from 1966-1968 and as the clinical director of the University of Rochester Cancer center in 1974, a position he held until 1995. During this period he was the principal investigator of the University of Rochester ECOG membership.
Dr. Bennett served as chair of the ASCO Public Relations Committee in the early 1980's as well as chair of the Education Committee for ASH. He was a founding member of the International Society for Geriatric Oncology.
Dr. Bennett is a member of numerous professional societies, including the American Medical Association, American Association for the Advancement of Science, American Association for Cancer research, American Society for Clinical Oncology, American Society of Hematology and the International Society of Hematology. Dr. Bennett is one of the world’s leading authorities on Myelodysplasia and was the founder and first chairman of the The Myelodysplastic Syndromes (MDS) Foundation from 1997-2010. Dr. Bennett has contributed over 550 publications to the medical literature as well as several books and served as Editor-in-Chief of the Leukemia Research Journal from 1993-2013.
Dr. John M. Bennett's research interests include:
- Myelodysplastic Syndromes
- Editorial: J Blood Res Hematol Dis 2015, 1:1
Richard T Silver and Hans Carl Hasselbalch
- Editorial: J Blood Res Hematol Dis 2016, 1:2
Theodoros P Vassilakopoulos and Sotirios G Papageorgiou
Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor PrognosisResearch Article: J Blood Res Hematol Dis 2016, 1:2
Pina J Trivedi, Dharmesh M Patel, Manisha M Brahmbhatt and Prabhudas S Patel
- Editorial: J Blood Res Hematol Dis 2016, 1:1
Luisa M Massimo
- Short Communication: J Blood Res Hematol Dis 2016, 1:1
Yasuhiro Maeda, Atsushi Okamoto, Shin-ichiro Kawaguchi, Akiko Konishi, Kenta Yamamoto, Go Eguchi and Terufumi Yamaguchi
- Review Article: J Blood Res Hematol Dis 2016, 1:2
Afaq Ahmad Khan, Zeeshan Ahmad Wani, Tufeel Kochak and Sonmoon Mohapatra
Autoimmune Thyroid Disease in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms Treated with Interferon-AlphaResearch Article: J Blood Res Hematol Dis 2016, 1:1
Cecilie Paulsrud, Hans C Hasselbalch and Ole Weis Bjerrum
Efficiency of Pre-Storage Leukoreduction of Red Cells: A Double Blind Quality Control Method, Transfusion medicineLetter to Editor: J Blood Res Hematol Dis 2016, 1:2
Setia Rasika, Arora Satyam, Handoo Anil and Kapoor Meenu
Timely Dosage Dependent Ethanolic Extract of Mangifera Indica Promotes Blood Cells Development and Weight GainResearch Article: J Blood Res Hematol Dis 2016, 1:2
Jimmy EO and Udo ES
- Review Article: J Blood Res Hematol Dis 2016, 1:1
Teresa Sadras, Richard J D’Andrea and Deborah L White